Document is current
Any future updates will be listed below
-
Authors
Rackaityte, E. http://orcid.org/0000-0003-3889-8082
Halkias, J. http://orcid.org/0000-0003-0721-8961
Fukui, E. M.
Mendoza, V. F.
Hayzelden, C.
Crawford, E. D. http://orcid.org/0000-0003-4182-2337
Fujimura, K. E.
Burt, T. D. http://orcid.org/0000-0001-7933-529X
Lynch, S. V. http://orcid.org/0000-0001-5695-7336
- License Information
-
More Information
Article History
Received: 10 December 2019
Accepted: 10 January 2020
First Online: 24 February 2020
Competing interests
: S.V.L. is co-founder of Siolta Therapeutics Inc. and serves as both a consultant and a member of its Board of Directors. The Regents of the UCSF have filed a patent application (PCT/US2019/045354) on behalf of S.V.L. and E.R. relating to the methods and compositions of fetal bacteria.
